Ipsen delivers strong sales in the first quarter of 2024, driven by growth platforms & new medicines, and confirms its ...
PARIS, FRANCE, 24 April 2024 - Ipsen (Euronext: IPN; ADR: IPSEY), a global specialty-care biopharmaceutical company, today presents its sales for the first quarter of 2024. Q1 2024 Q1 2023 % change €m €m Actual CER1 Growth platforms2 509. …